Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-31 @ 3:47 AM
Study NCT ID:
NCT03450057
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2018-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Sponsor:
Hellenic Society of Hematology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-13
First Submit QC Date:
None
Study First Post Date:
2018-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-10-13
Results First Submit QC Date:
None
Results First Post Date:
2023-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-27
Last Update Post Date:
2024-03-29
Last Update Post Date Type:
ACTUAL